In:
PLOS ONE, Public Library of Science (PLoS), Vol. 17, No. 9 ( 2022-9-15), p. e0273914-
Abstract:
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines by national immunization programs in single studies spanning multiple countries and continents are limited but critically needed to answer public health questions on vaccines, such as comparing immune responses to different vaccines and among different populations.
Type of Medium:
Online Resource
ISSN:
1932-6203
DOI:
10.1371/journal.pone.0273914
DOI:
10.1371/journal.pone.0273914.g001
DOI:
10.1371/journal.pone.0273914.g002
DOI:
10.1371/journal.pone.0273914.t001
DOI:
10.1371/journal.pone.0273914.t002
DOI:
10.1371/journal.pone.0273914.t003
DOI:
10.1371/journal.pone.0273914.r001
DOI:
10.1371/journal.pone.0273914.r002
Language:
English
Publisher:
Public Library of Science (PLoS)
Publication Date:
2022
detail.hit.zdb_id:
2267670-3
Bookmarklink